How to Define Mild to Severe Hidradenitis Suppurativa? A Simple New Tool Based on Latent Class Analysis of EPIVER Data Study.
Hurley stage
classification
hidradenitis suppurativa
latent class
severity
Journal
Clinical, cosmetic and investigational dermatology
ISSN: 1178-7015
Titre abrégé: Clin Cosmet Investig Dermatol
Pays: New Zealand
ID NLM: 101543449
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
03
2022
accepted:
31
05
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
24
6
2022
Statut:
epublish
Résumé
Hidradenitis suppurativa (HS) is an inflammatory skin disease characterized by recurrent or chronic painful and suppurating lesions in the apocrine gland-bearing regions. The lack of knowledge about HS and its extremely heterogeneous clinical presentation, in terms of both lesion appearance and sites of involvement, frequently delay its diagnosis for several years. Objectives: in this study, using the latent class analysis, it was demonstrated that severity of HS could be evaluated not only with clinical or surgical characteristics but also with gender specificities. Clinical and sociodemographic data of HS patients were retrospectively analysed with the latent class method in order to create a classification tool of disease severity. From the study of 1428 HS patients (544 men and 884 women), two classification models, depending on gender, were developed. Each classification model was composed of three distinct latent classes clearly identified and defined from mild-to-severe cases of HS. These classification models of HS severity were not distorted by patient ages and were coherent with Hurley stages but were more clinically precise. In this study, a convenient classification tool, useful for facilitating decision support in routine practice, has been developed. This tool could be used to define clinical subgroups within a study population.
Identifiants
pubmed: 35734147
doi: 10.2147/CCID.S362622
pii: 362622
pmc: PMC9208478
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1091-1103Informations de copyright
© 2022 Perrot et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Br J Dermatol. 2009 Oct;161(4):831-9
pubmed: 19438453
J Cutan Med Surg. 2020 Jan/Feb;24(1):55-59
pubmed: 31698918
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S8-11
pubmed: 26470623
J Invest Dermatol. 2013 Jun;133(6):1506-11
pubmed: 23235532
Arch Plast Surg. 2019 Nov;46(6):566-571
pubmed: 31775210
JAMA Dermatol. 2017 Aug 1;153(8):760-764
pubmed: 28492923
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):e256
pubmed: 30767281
Br J Dermatol. 2010 Jun;162(6):1261-8
pubmed: 20184581
Dermatol Clin. 2016 Jan;34(1):45-9
pubmed: 26617357
Ital J Dermatol Venerol. 2021 Apr;156(2):235-239
pubmed: 30298709
Br J Dermatol. 2014 Oct;171(4):819-24
pubmed: 24804604
Skin Appendage Disord. 2018 Oct;4(4):281-285
pubmed: 30410897
Br J Dermatol. 2016 Aug;175(2):263-72
pubmed: 26873867
JAMA. 2017 Nov 28;318(20):2019-2032
pubmed: 29183082
J Invest Dermatol. 2013 Jun;133(6):1453-6
pubmed: 23673498
Cochrane Database Syst Rev. 2015 Oct 07;(10):CD010081
pubmed: 26443004
Dermatol Surg. 2013 Dec;39(12):1835-42
pubmed: 24118433